GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xcorporeal Inc (GREY:XCRP) » Definitions » Asset Turnover

Xcorporeal (Xcorporeal) Asset Turnover : 0.00 (As of Sep. 2009)


View and export this data going back to . Start your Free Trial

What is Xcorporeal Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Xcorporeal's Revenue for the three months ended in Sep. 2009 was $0.00 Mil. Xcorporeal's Total Assets for the quarter that ended in Sep. 2009 was $1.22 Mil. Therefore, Xcorporeal's Asset Turnover for the quarter that ended in Sep. 2009 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Xcorporeal's annualized ROE % for the quarter that ended in Sep. 2009 was 235.00%. It is also linked to ROA % through Du Pont Formula. Xcorporeal's annualized ROA % for the quarter that ended in Sep. 2009 was -505.25%.


Xcorporeal Asset Turnover Historical Data

The historical data trend for Xcorporeal's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcorporeal Asset Turnover Chart

Xcorporeal Annual Data
Trend Feb99 Feb00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xcorporeal Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xcorporeal's Asset Turnover

For the Medical Devices subindustry, Xcorporeal's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xcorporeal's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Xcorporeal's Asset Turnover falls into.



Xcorporeal Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Xcorporeal's Asset Turnover for the fiscal year that ended in Dec. 2008 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2008 )/( (Total Assets (A: Dec. 2007 )+Total Assets (A: Dec. 2008 ))/ count )
=0/( (17.253+4.351)/ 2 )
=0/10.802
=0.00

Xcorporeal's Asset Turnover for the quarter that ended in Sep. 2009 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Sep. 2009 )/( (Total Assets (Q: Jun. 2009 )+Total Assets (Q: Sep. 2009 ))/ count )
=0/( (1.341+1.099)/ 2 )
=0/1.22
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Xcorporeal  (GREY:XCRP) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Xcorporeal's annulized ROE % for the quarter that ended in Sep. 2009 is

ROE %**(Q: Sep. 2009 )
=Net Income/Total Stockholders Equity
=-6.164/-2.623
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-6.164 / 0)*(0 / 1.22)*(1.22/ -2.623)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.4651
=ROA %*Equity Multiplier
=-505.25 %*-0.4651
=235.00 %

Note: The Net Income data used here is four times the quarterly (Sep. 2009) net income data. The Revenue data used here is four times the quarterly (Sep. 2009) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Xcorporeal's annulized ROA % for the quarter that ended in Sep. 2009 is

ROA %(Q: Sep. 2009 )
=Net Income/Total Assets
=-6.164/1.22
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.164 / 0)*(0 / 1.22)
=Net Margin %*Asset Turnover
= %*0
=-505.25 %

Note: The Net Income data used here is four times the quarterly (Sep. 2009) net income data. The Revenue data used here is four times the quarterly (Sep. 2009) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Xcorporeal Asset Turnover Related Terms

Thank you for viewing the detailed overview of Xcorporeal's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Xcorporeal (Xcorporeal) Business Description

Traded in Other Exchanges
N/A
Address
80 Empire Drive, Lake Forest, CA, USA, 92630
Website
Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.
Executives
Kelly J. Mccrann director, officer: Chairman and CEO 11150 SANTA MONICA BLVD #1500, LOS ANGELES CA 90025
Daniel S Goldberger officer: Chief Executive Officer 24 CARPENTER ROAD, CHESTER NY 10918
Marc G Cummins director C/O PRIME LOGIC CAPITAL, LLC, 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Prime Logic Capital, Llc 10 percent owner 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Robert Weinstein officer: Chief Financial Officer 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Terren S Peizer director, 10 percent owner, officer: Executive Chairman 11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Jay Wolf director 981 LINDA FLORA DRIVE, LOS ANGELES, CA 90049
Herve De Kergrohen director 22 CHEMIN DU NANTET, COLLONGE-BELLERIVE V8 CH1245
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Lawrence Lacerte 10 percent owner C/O TERAGLOBAL COMMUNICATIONS CORP, 9171 TOWNE CENTRE DRIVE SUITE 600, SAN DIEGO CA 92122

Xcorporeal (Xcorporeal) Headlines